MoneyWorks4Me

FDC - Quaterly Results

28 May 2025 Evaluate
The revenue zoomed 6.11% to Rs. 4820.04 millions for the quarter ended March 2025 as compared to Rs. 4542.34 millions during the corresponding quarter last year.Profit for the quarter ended March 2025 increased merely by0.04% to Rs. 482.15  millions from Rs. 481.95 millions.Operating profit for the quarter ended March 2025 rose to 842.52 millions as compared to 785.56 millions of corresponding quarter ended March 2024.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202503 202403 % Var 202503 202403 % Var 202503 202403 % Var
Sales 4820.04 4542.34 6.11 20701.12 19161.87 8.03 20701.12 19161.87 8.03
Other Income 314.26 207.16 51.70 1055.18 1032.16 2.23 1055.18 1032.16 2.23
PBIDT 842.52 785.56 7.25 4257.65 4416.74 -3.60 4257.65 4416.74 -3.60
Interest 11.82 9.44 25.21 44.88 40.00 12.20 44.88 40.00 12.20
PBDT 830.70 776.12 7.03 4212.77 4376.74 -3.75 4212.77 4376.74 -3.75
Depreciation 155.29 103.95 49.39 536.06 397.29 34.93 536.06 397.29 34.93
PBT 675.41 672.17 0.48 3676.71 3979.45 -7.61 3676.71 3979.45 -7.61
TAX 193.26 190.22 1.60 940.46 907.82 3.60 940.46 907.82 3.60
Deferred Tax 37.36 58.22 -35.83 90.46 51.63 75.21 90.46 51.63 75.21
PAT 482.15 481.95 0.04 2736.25 3071.63 -10.92 2736.25 3071.63 -10.92
Equity 162.81 162.81 0.00 162.81 162.81 0.00 162.81 162.81 0.00
PBIDTM(%) 17.48 17.29 1.07 20.57 23.05 -10.77 20.57 23.05 -10.77
Peers
Company Name CMP
Sun Pharma. Inds. 1853.50
Dr. Reddys Labs. 1202.80
Cipla 1397.20
Lupin 2090.00
Zydus Lifesciences 1202.00
View more..